Abstract

BackgroundRabies remains a neglected and poorly controlled disease throughout the developing world, particularly in Africa and Asia, where most human rabies deaths occur.ObjectiveThis study aimed to describe the epidemiology of rabies exposures, its trend, and its geographical distribution in Yemen.MethodsCumulative data from a rabies surveillance system for the period 2011-2017 were obtained from the National Rabies Control Program as paper-based annual reports. Data included the number of persons bitten by a suspected rabid animal, their gender and age, and the result of the animal’s laboratory test. Human cases were defined as those exposed to rabies virus bitten by a suspected rabid animal, exposed to a confirmed rabid animal and then received postexposure prophylaxis (PEP), and deaths occurred after exposure to a confirmed rabid animal after having rabies symptoms during 2011-2017.ResultsFrom 2011 to 2017, a total of 76,049 persons were bitten by a suspected rabid animal. Of these, 21,927 (28.83%) were exposed to positively confirmed rabid animals and then received PEP, and 295 (0.38%) rabies-related deaths occurred. Of all cases with rabies exposure, 50,882 (66.91%) were males. The most affected age group by animal bites (31,816/76,041, 41.84%), positive exposure (8945/21,927, 40.79%), and rabies deaths (143/295, 48.47%) was 5-14 years. Rabies vaccines and immunoglobulins quantities were least available in 2016 and 2017. The annual incidence rate of exposure to animal bites and rabies exposure was 50 and 14 per 100,000, respectively. The annual mortality rate was 2 per 1,000,000. The highest incidence rate of animal bites was in Dhamar (112 per 100,000) and Ibb (94 per 100,000), whereas the highest incidence of exposed cases was in Amanat Al Asimah (40 per 100,000) and Ibb (37 per 100,000). Mortality rate was the highest in Amanat Al Asimah (6 deaths per 1,000,000) followed by Ibb and Dhamar (4 deaths per 1,000,000 in both).ConclusionsRabies remains a worrying health problem in Yemen with higher percentage reported among children and males. Targeting school-age populations by education, communication, and information campaigns about preventive measures is strongly recommended. An electronic system should be introduced to improve reporting. It is important to have a sufficient supply of vaccines and immunoglobulins in control units, especially in the at-risk or impacted governorates. Future studies are suggested to determine incidences and risk factors of disease progression.

Highlights

  • Rabies is a zoonotic progressive neurological infection in humans and other mammals caused by the rabies virus, which belongs to the genus Lyssavirus [1]

  • It is important to have a sufficient supply of vaccines and immunoglobulins in control units, especially in the at-risk or impacted governorates

  • This study aimed to describe the epidemiology of human rabies exposure, its trend, and its geographical distribution in Yemen

Read more

Summary

Introduction

Rabies is a zoonotic progressive neurological infection in humans and other mammals caused by the rabies virus, which belongs to the genus Lyssavirus (family: Rhabdoviridae) [1]. Over 99% of rabies cases are caused by bites of rabid dogs [1,2]. Rabies is a fatal disease with 2 clinical manifestations: furious (classical or encephalitic) and paralytic. Furious rabies accounts for nearly 80% of cases [3]. More specific symptoms appear and may include insomnia, anxiety, confusion, slight or partial paralysis, excitation, hallucinations, agitation, hypersalivation, difficulty swallowing, and hydrophobia. There is no specific treatment for rabies, and as a result, death usually occurs within days of the onset of these symptoms. Safe and effective animal and human vaccines are widely available for the prevention and control of rabies [3,4]. Rabies remains a neglected and poorly controlled disease throughout the developing world, in Africa and Asia, where most human rabies deaths occur

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call